text: The findings of this large study strongly support the notion that @GENE$ mutations characterize a subgroup of bladder cancers with good prognosis; patients with @DISEASE$ TaG1 tumors have a higher risk of recurrence; and the F386L variant is selectively associated with low-grade tumors.